CLINICAL TRIAL
Published on 16 Feb 2023
The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients
doi 10.3389/fphar.2023.1080730
- 2,370 views
- 3 citations
- Frontiers in Pharmacology
- Inflammation Pharmacology
- Research Topics
- Antibody-Drugs and Natural Medicines for Autoimmune Diseases
Antibody-Drugs and Natural Medicines for Autoimmune Diseases
5,253
Total downloads
17k
Total views and downloads
Articles
SYSTEMATIC REVIEW
Published on 13 Feb 2023
Adverse events of tumor necrosis factor alpha inhibitors for the treatment of ankylosing spondylitis: A meta-analysis of randomized, placebo-controlled trials
doi 10.3389/fphar.2023.1084614
- 2,743 views
- 5 citations
REVIEW
Published on 17 Jan 2023
Perturbed autophagy intervenes systemic lupus erythematosus by active ingredients of traditional Chinese medicine
doi 10.3389/fphar.2022.1053602
- 3,976 views
- 5 citations
ORIGINAL RESEARCH
Published on 16 Jan 2023
Association between genetic variants and development of antibodies to infliximab: A cross-sectional study in Chinese patients with Crohn’s disease
doi 10.3389/fphar.2023.1096816
- 1,361 views
- 6 citations
ORIGINAL RESEARCH
Published on 07 Nov 2022
Connective tissue disease-related interstitial lung disease is alleviated by tripterine through inhibition of the PI3K/Akt, apoptosis, and TNF-α signalling pathways
doi 10.3389/fphar.2022.990760
- 1,779 views
- 3 citations
